In an increasingly competitive and data-driven business world, organizations must rely on accurate insights to guide their strategies and decisions. Understanding market behavior, tracking industry developments, and identifying growth opportunities are no longer optional—they are essential for survival and long-term success. Recognizing this growing demand for reliable intelligence, Emergen Research has launched its comprehensive Intravascular Ultrasound IVUS Devices market research content, a powerful resource designed to support businesses across various industries.
One of the most notable aspects of this research is its strong focus on delivering actionable insights. Instead of simply presenting large volumes of raw data, the report is structured to help businesses translate information into practical strategies. Whether a company is planning expansion, optimizing operations, or exploring new opportunities, the recommendations provided in this content can play a crucial role in guiding decision-making processes.
The Intravascular Ultrasound (IVUS) Devices Market is expected to grow from an estimated USD 1.1 billion in 2024 to USD 1.8 billion in 2033, at a CAGR of 5.50%.
Heart disease is one of the main causes of death worldwide, hence there is a constant need for advanced diagnostic and therapeutic tools like Intravascular Ultrasound (IVUS) Devices. According to data in WHO, 2019 CVDs account for 17.9 million deaths worldwide, constituting 32% of the total death tolls, while more than 85% were due to heart attack and stroke.
Lifestyle factors such as poor food, smoking, physical inactivity, and rising rates of obesity and diabetes are blamed for the growing prevalence of CVDs. According to the Centers for Disease Control and Prevention, heart disease causes 1 in 5 deaths in the United States or 697,000 deaths annually. These figures illustrate the growing need for advanced diagnostic methods in order to diagnose and treat heart conditions accurately.
Cardiologists now rely greatly on IVUS devices as they offer them access to high-resolution, comprehensive, cross-sectional images of blood arteries. IVUS enhances the precision of interventional treatments, such as PCI, offering a precise assessment of the arterial plaque and vessel walls.
With increased necessity in the fight against CVDs, governments and public health organisations worldwide acknowledge its importance. For instance, the National Health Service of the United Kingdom has added IVUS to its pathways for cardiac care further to enhance the accuracy of results in diagnosis and treatment.
For the evaluation of complex coronary lesions and to optimise the placement of a stent, the American College of Cardiology recommends IVUS. As a result of such recommendations, it has resulted in hospitals now use more IVUS devices, and this is responsible for enhancing market growth.
CVDs are not just confined to developed nations. In developing countries, especially the Asia-Pacific, there is a sharp growth in cases of heart disease. It goes on to rank amongst those countries that contribute significantly towards the world's cardiovascular mortality since over 4.77 million deaths are recorded by the WHO every year attributed to CVDs.
In a bid to further increase healthcare accessibility and affordability, the Government of India launched the Ayushman Bharat Health Mission by looking at this trend. Funding for hospitals and diagnostic facilities is made possible and facilitates the use of some cutting-edge medical technologies, which include IVUS.
The Intravascular Ultrasound IVUS Devices market research content has been developed through a rigorous process that combines advanced data analytics with deep industry expertise. Emergen Research’s team of analysts has carefully studied historical data, current trends, and future projections to create a comprehensive and reliable resource. The content includes a wide range of materials such as detailed market reports, whitepapers, case studies, and trend analyses. These resources cover multiple sectors including healthcare, technology, finance, manufacturing, and consumer goods, ensuring that the insights are relevant to businesses operating in diverse markets.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4368
Competitive landscape:-
The report also provides a comprehensive overview of the competitive landscape, which is critical for businesses aiming to maintain a strong market position. It highlights key players in the global Intravascular Ultrasound IVUS Devices market and offers insights into their strategies, strengths, and recent developments. Information related to mergers and acquisitions, collaborations, technological advancements, and product launches is also included. This helps businesses understand how competitors are evolving and identify opportunities to differentiate themselves.
Advancements in IVUS Technology Boost the Market Growth
Intravascular ultrasound devices are seeing constant innovation. The progress made in this technology, such as a higher resolution of imaging, depth of the images taken, and precision in the diagnostic capabilities of the tool, have plugged the necessary gaps in the cardiovascular sector.
Innovations in this regard have received support from bodies like the U.S. Food and Drug Administration and European Medicines Agency for approval, which will contribute to its growth in the market. However, one of the most impactful advancements is the introduction of Capacitive Micromachined Ultrasonic Transducer (CMUT) technology.
It allows for better miniaturisation of devices while maintaining superior quality in imaging. For example, IVUS systems incorporating CMUTs provide in-depth assessments of plaque morphology, thus allowing for targeted interventions during procedures such as stenting and atherectomy.
According to the American Heart Association, "These advances enhance diagnostic speed, reduce procedural complications, and improve patient outcomes". Moreover, by introducing automated pullback mechanisms and integration with other imaging modalities, such as Optical Coherence Tomography, IVUS devices become even more versatile.
The National Institutes of Health has funded research programs that explore these technologies for their potential to revolutionise vascular imaging. These technological advancements have the most significant impact on advanced healthcare infrastructure regions.
For instance, cardiac catheterisation labs in the United States and Europe are increasingly taking up next-generation IVUS devices with reimbursement policies from government health programs like Medicare. The development of portable and wireless IVUS systems is also expanding the scope of use in remote and underserved areas, thereby broadening the market's reach.
Another significant feature of the report is its detailed segmentation analysis. By dividing the Intravascular Ultrasound IVUS Devices market into various categories such as product types, applications, end-user industries, and geographical regions, the report provides a deeper understanding of how different segments perform. This enables businesses to identify high-growth areas and focus their strategies accordingly. Understanding these segment-level dynamics can help organizations optimize resource allocation and improve overall efficiency.
The competitive landscape of the IVUS devices market is characterised by the top players such as Boston Scientific, Philips, and Terumo, with a keen focus on innovations and partnerships to strengthen their market position. Government-backed healthcare modernisation initiatives, like the Healthy China 2030 Plan, drive the industry expansion.
The outlook remains positive with technological advancement, the growing prevalence of cardiovascular disease, and an increase in the adoption of minimally invasive procedures. Emerging markets, especially Asia-Pacific, hold significant opportunities for manufacturers in terms of local partnerships and value for money.
In April 2024, Provisio Medical announced FDA clearance for its Provisio IVUS System. Leveraging Sonic Lumen Tomography technology, this system addresses critical needs for vascular specialists by providing automatic, real-time numeric measurements of blood vessel lumens, eliminating the need for complex image interpretation.
Some of the key companies in the global Intravascular Ultrasound (IVUS) Devices Market include:
- Canon Medical Systems Corp.
- Boston Scientific Corp.
- GE Healthcare
- Philips
- Siemens Healthcare
- Hitachi
- Mindray Medical International Ltd.
- Fujifilm Corp.
- Samsung Medison
- Chison Medical Technologies
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/4368
Beyond competitive and segmentation analysis, the report is designed to cater to a wide range of stakeholders. Investors, venture capitalists, startups, and large enterprises can all benefit from the insights provided. Additionally, consulting firms, research organizations, and government bodies can use the information to support policy-making and strategic planning.
By Modality Outlook (Revenue, USD Billion; 2020-2033)Â
- Virtual Histology IVUS
- iMAP IVUS
- Integrated Backscatter IVUS
By Product Outlook (Revenue, USD Billion; 2020-2033)Â
- Consoles
- Accessories
- Catheters
- Guidewires
- Others
By End-use Outlook (Revenue, USD Billion; 2020-2033)Â
- Hospitals
- Diagnostic Imaging Centers
- Academic And Research Institutes
By Regional Outlook (Revenue, USD Billion; 2020-2033)Â
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
One of the key strengths of Emergen Research’s content is its commitment to providing up-to-date information. Markets are constantly changing due to technological advancements, economic shifts, and evolving consumer preferences. By regularly updating its research, Emergen Research ensures that businesses always have access to the latest insights. This allows organizations to remain agile and adapt quickly to new developments.
Another important advantage of this research is the inclusion of expert perspectives. The analysts behind the report bring years of experience and a deep understanding of industry trends. Their ability to interpret complex data and identify meaningful patterns adds significant value to the content. These insights not only help businesses understand current market conditions but also prepare for future challenges and opportunities.
Emergen Research also emphasizes clarity and usability in its content. The information is presented in a structured and easy-to-understand format, making it accessible even to those who may not have a strong background in market analysis. This user-friendly approach ensures that businesses of all sizes can benefit from the research.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/intravascular-ultrasound-ivus-devices-market
About Emergen Research
Emergen Research is a leading market research and consulting company that provides syndicated reports, customized research solutions, and expert consulting services. The company focuses on helping businesses understand market trends, analyze consumer behavior, and identify growth opportunities. With a strong commitment to accuracy and quality, Emergen Research continues to support organizations in making informed and strategic decisions.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Comments